Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 878Pancreatic Neoplasms 572Carcinoma, Hepatocellular 542Stomach Neoplasms 512Esophageal Neoplasms 312Rectal Neoplasms 280Colonic Neoplasms 254Breast Neoplasms 203Neoplasms 201Liver Neoplasms 187Lung Neoplasms 174Carcinoma, Non-Small-Cell Lung 174Cholangiocarcinoma 153Ovarian Neoplasms 141Neoplasm Metastasis 135Gastrointestinal Neoplasms 133Esophageal Squamous Cell Carcinoma 130Melanoma 103Prostatic Neoplasms 98Biliary Tract Neoplasms 95Endometrial Neoplasms 83Uterine Cervical Neoplasms 79Head and Neck Neoplasms 72Squamous Cell Carcinoma of Head and Neck 69Carcinoma, Renal Cell 58Sarcoma 54Adenocarcinoma Of Esophagus 54Urinary Bladder Neoplasms 53Anus Neoplasms 52Triple Negative Breast Neoplasms 48

Interventions

Sampling Studies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Osteochondroma × Gastrointestinal × Clear all
NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Dana-Farber Cancer Institute

Recruiting
5,000 enrolled
GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡